Health Tech Talk Live Archives - 1-800-PublicRelations "1800pr"

10 Mar

iHeart Radio’s “HealthTech Talk” Show to Feature MYOS Corporation’s Ingredient Fortetropin™ in Exclusive Interview With Company Chairman

Dr. Robert Hariri to Be Interviewed by Ben Chodor on March 7, 2015 at 3:00pm ET/12:00pm PT/2:00pm CT

CEDAR KNOLLS, NJ–(Mar 6, 2015) – MYOS Corporation (“MYOS” or the “Company”) (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve human muscle health and performance, announced today that its Chairman of the Board, Dr. Robert J. Hariri, will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios — 640 WGST AM tomorrow, at 3:00pm ET.

In this exclusive interview, Dr. Hariri will discuss the Company’s all-natural ingredient, Fortetropin™, the first clinically demonstrated myostatin inhibitor, and soon-to-be launched product line RE, the Company’s 2014 milestones and touch on MYOS’s 2015 outlook and the recent outspoken celebrity attention MYOS has been garnering from Justin Bieber and the world’s strongest man. Fortetropin™ is manufactured to optimize biological activity to build healthy lean muscle. MYOS believes Fortetropin™ has the potential to redefine existing standards for muscle health and human longevity.

MYOS encourages all shareholders, analysts, industry professionals and interested parties to tune in live to the interview with Dr. Hariri. The details and link to iHeart Radio’s live worldwide stream are below.

Date: March 7, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT
Network: iHeart Radio/ Clear Channel
Station: 640 WGST AM
Show: Health Tech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more information about please visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About HealthTech Talk Show
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

About Dr. Robert Hariri
Dr. Robert Hariri is a surgeon, biomedical scientist and highly successful serial entrepreneur in two technology sectors: biomedicine and aerospace. The Chairman, Founder, Chief Scientific Officer, and former Chief Executive Officer of Celgene Cellular Therapeutics, one of the world’s largest human cellular therapeutics companies, Dr. Hariri has pioneered the use of stem cells to treat a range of life threatening diseases and has made transformative contributions in the field of tissue engineering. In addition to his role at Celgene Cellular Therapeutics, Dr. Hariri is also Vice-Chairman & Co-Founder of Human Longevity, Inc. (HLI).

His activities and experience includes academic neurosurgeon at Cornell, businessman, military surgeon and aviator and aerospace innovator. Dr. Hariri has over 90 issued and pending patents, has authored over 100 published chapters, articles and abstracts and is most recognized for his discovery of pluripotent stem cells from the placenta and as a member of the team which discovered the physiological activities of TNF (tumor necrosis factor).

Dr. Hariri was recipient of the Thomas Alva Edison Award in 2007 and 2011, The Fred J. Epstein Lifetime Achievement Award and has received numerous other honors for his many contributions to biomedicine and aviation. Dr. Hariri also serves on numerous Boards of Directors including Myos Corporation and Provista Diagnostics. Dr. Hariri is an Adjunct Associate Professor of Pathology at the Mount Sinai School of Medicine and a member of the Board of Visitors of the Columbia University School of Engineering & Applied Sciences and the Science & Technology Council of the College of Physicians and Surgeons, and is a member of the scientific advisory board for the Archon X PRIZE for Genomics, which is awarded by the X PRIZE Foundation. Dr. Hariri is also a Trustee of the Liberty Science Center and has been appointed Commissioner of Cancer Research by NJ Governor Christie. Dr. Hariri is also a member of the Board of Trustees of the J. Craig Venter Institute.

A jet-rated commercial pilot with thousands of hours of flight time in over 60 different military and civilian aircraft, Dr. Hariri has also produced several feature films as well as documentaries on global societal issues.

About MYOS Corporation
MYOS is an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS is the owner of Fortetropin™, the first clinically proven natural myostatin inhibitor. Myostatin is a natural regulatory protein, which inhibits muscle growth and recovery. Medical literature suggests that lowering myostatin levels has many potential health benefits including increased muscle mass, healthy weight management, improved energy levels, stimulation of muscle healing as well as treating sarcopenia, a condition of age-related loss of muscle mass. To discover why MYOS is known as “The Muscle Company,”™ visit www.myoscorp.com.

The Company’s first commercial product containing Fortetropin (MYO-T12), is distributed by Maximum Human Performance (MHP) under the brand name MYO-X^® and is currently available on popular retailer websites including http://mhpstrong.com,www.bodybuilding.com, www.amazon.com and in specialty retailers including GNC and Vitamin Shoppe and others. MYOS believes that Fortetropin, as well as future products it envisions, will redefine existing standards for muscle health.

Forward-Looking Statements
Any statements in this release that are not historical facts are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to the successful continued research of Fortetropin™ and its effects on myostatin inhibition, inflammatory cytokine levels and cholesterol levels, customer demand for our products, market acceptance of our existing and future products, the ability to create new products through research and development, growth in our revenue, the successful entry into new markets including the age management market, the ability to successfully develop and launch our own core branded products, the ability to collect our accounts receivable from our distributors, the ability to attract additional investors and increase shareholder value, the ability to generate the forecasted revenue stream and cash flow from sales of Fortetropin and MYO-X^®, the ability to achieve a sustainable profitable business, the effect of economic conditions, the ability to protect our intellectual property rights, the ability to maintain and expand our manufacturing capabilities and reduce the costs of our products, the ability to enter into strategic relationships with new distributors, the ability to comply with NASDAQ’s continuing listing standards, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, and other factors discussed from time to time in our Securities and Exchange Commission filings. We undertake no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure or prevent any disease.

A 1800PublicRelations.com PR Event…

CONTACT INFORMATION

Interview Press / Media Contact:
Matthew Bird
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1-800-PublicRelations, 1800PR, bionutrition, biotherapeutics, Dr. Robert J. Hariri, Fitness, Fortetropin, Health Tech Talk Live, HealthTech Talk, Muscle Health, MYO-X, MYOS Corporation, myostatin inhibitor Comments Off Read more...

03 Mar

Aradigm Corporation President & CEO Dr. Igor Gonda, Ph.D. to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live”

Live Interview to Air on February 28th, 2015, Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT

HAYWARD, CA–(Feb 27, 2015) – Aradigm Corporation (NASDAQ: ARDM), a company actively engaged in fulfilling the promise of developing inhalation drug products that could revolutionize the quality of life of patients with severe pulmonary disease, announced today that President and Chief Executive Officer (CEO) Dr. Igor Gonda, Ph.D. will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM tomorrow, at 3:00pm ET. In this exclusive double-segment interview, Dr. Gonda will discuss how the company has attracted an outstanding team of scientists, engineers and clinical experts who have been at the forefront of development of advanced inhalation delivery products like AERx®, a pulmonary delivery platform.

Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: February 28, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: iHeart Radio/ Clear Channel
Station: 640 WGST AM
Show: Health Tech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About Aradigm Corporation
Aradigm is actively engaged in fulfilling the promise of developing inhalation drug products that could revolutionize the quality of life of patients with severe pulmonary disease.

Since 1991, the company has attracted an outstanding team of scientists, engineers and clinical experts who have been at the forefront of development of advanced inhalation delivery products. This team for example, pioneered the AERx® pulmonary delivery platform that was tested in thousands of patients with drugs and biologics including insulin, fentanyl, erythropoietin and nicotine. With the depth of experience and expertise in inhalation delivery, Aradigm is uniquely positioned to develop a portfolio of its own products to treat patients with severe respiratory diseases. The current pipeline includes an inhaled antibiotic being developed for the treatment of bronchiectasis*, cystic fibrosis and for biodefense, and inhaled nicotine for smoking cessation.

About President and CEO Dr. Igor Gonda, Ph.D.
Dr. Gonda has served as President and Chief Executive Officer since August 2006, and as a director since September 2001. From December 2001 to August 2006, Dr. Gonda was the Chief Executive Officer and Managing Director of Acrux Limited, a publicly traded specialty pharmaceutical company located in Melbourne, Australia. From July 2001 to December 2001, Dr. Gonda was our Chief Scientific Officer and, from October 1995 to July 2001, was our Vice President, Research and Development. From February 1992 to September 1995, Dr. Gonda was a Senior Scientist and Group Leader at Genentech, Inc. leading inhalation development of products for severe respiratory disease. Prior to that, Dr. Gonda held academic positions at the University of Aston in Birmingham, United Kingdom, and the University of Sydney, Australia. Dr. Gonda holds a B.Sc. in Chemistry and a Ph.D. in Physical Chemistry from Leeds University, United Kingdom. Dr. Gonda was the Chairman of our Scientific Advisory Board until August 2006.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

A 1800PublicRelations.com PR Event…

Interview Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog 1800 Public Relations, 1800PR, 640 WGST AM, Aradigm, ARDM, Ben Chodor, Clear Channel, Health Tech Talk, Health Tech Talk Live, Igor Gonda, iHeart Radio, NASDAQ Comments Off Read more...

24 Feb

Chairman & CEO Rik J. Deitsch of Nutra Pharma Corporation to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live”

Live Interview to Air February 21, 2015, Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT

CORAL SPRINGS, FL–(Feb 20, 2015) – Nutra Pharma Corporation (OTC PINK: NPHC), a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases, announced today that Chairman and Chief Executive Officer (CEO) Rik J. Deitsch will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM this Saturday at 3:00pm ET. In this exclusive double-segment interview, Mr. Deitsch will discuss how Nutra Pharma is currently expanding its OTC retail sales of their pain therapies: Nyloxin® and Pet Pain-Away. He also discusses the clinical development of its first two therapeutic products. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: February 21, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: iHeart Radio / Clear Channel
Station: 640 WGST AM
Show: HealthTech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About Nutra Pharma Corporation
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. The Company currently markets drug products for the treatment of pain under the brands Nyloxin® and Pet Pain-Away.

About CEO Rik J. Deitsch
Nutra Pharma’s Chairman and Chief Executive Officer holds both a B.S. in Chemistry and an M.S. in Biochemistry and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic. Mr. Deitsch is the author of two books: Are You AgeWise: A Guide to Healthy Aging, and Invisible Killers: the Truth About Environmental Genocide. He is also an adjunct professor, teaching several courses for Florida Atlantic University’s College of Business and Continuing Education Department.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About HealthTech Talk Live
HealthTech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com. If you’re interested in being a guest on HealthTech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Interview Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog 1800 Public Relations, 1800PR, 1800publicrelations.com, Ben Chodor, Clear Channel, Health Tech Talk, Health Tech Talk Live, iHeart Radio, NPHC, Nutra Pharma, OTC PINK, Rik J. Deitsch Comments Off Read more...

18 Feb

Starpharma Holdings Limited CEO Dr. Jackie Fairley to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live” on February 14, 2015

Live Interview Airs on “Health Tech Talk Live,” Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT

ATLANTA, GA–(Feb 13, 2015) – Starpharma Holdings Limited (ASX: SPL) (OTCQX: SPHRY), a company that researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and agrochemical applications announced today that Chief Executive Officer (CEO), Dr. Jackie Fairley will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcast nationwide on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM this Saturday at 3:00pm ET. In this exclusive double-segment interview, Dr. Fairley will discuss VivaGel®, the company’s development of the world’s first antiviral condom (the VivaGel® condom) which was recently launched in Australia by Starpharma’s partner, Ansell. Dr Fairley will also talk about Starpharma’s current US Phase III clinical trials of VivaGel® for the prevention of recurrent bacterial Vaginosis as well as its development of the clinical trial of the company’s improved version of cancer drug docetaxel (Taxotere). The Company’s product, DEP™ docetaxel is a dendrimer-enhanced nanoparticle formulation which is currently in a Phase I clinical trial in cancer patients. DEP™ docetaxel has shown a number of benefits compared to the commercial version of docetaxel, Taxotere® and this platform delivery technology can be used to improve other pharmaceuticals as well. Starpharma also applies its proprietary dendrimers to improve the performance of agrochemical products such as glyphosate (the active ingredient in Roundup®) and has a series of partnerships with leading industry players. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: February 14, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: iHeart Radio/ Clear Channel
Station: 640 WGST AM
Show: HealthTech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About Starpharma Holdings Limited
Starpharma Holdings Limited (ASX: SPL) (OTCQX: SPHRY) is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications.

Starpharma’s underlying technology is built around dendrimers — a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses. Starpharma has three core development programs: VivaGel® portfolio, DEP™ drug delivery, and agrochemicals with the Company developing a number of products internally and others via commercial partnerships.

Starpharma’s lead products are based on VivaGel® (SPL7013, astodrimer sodium), a proprietary dendrimer. VivaGel® formulated as a mucoadhesive gel and delivered vaginally is under clinical development for the management and prevention of bacterial vaginosis (BV). Starpharma has also signed separate license agreements with Ansell Limited (ASX: ANN) and Okamoto Industries Inc., (TSE: JP3192800005) to market a value-added, VivaGel® condom. The VivaGel® condom is available for purchase in Australia under Ansell’s Lifestyles® Dual Protect™ brand. Ansell manufactures and sells leading condom brands worldwide, including Lifestyles®, ZERO® and SKYN®. Okamoto is the market leader for condoms sold in Japan, which is the world’s second largest condom market.

In the wider pharmaceutical and life science fields, Starpharma has both partnered and internal programs in Drug Delivery. A number of dendrimer-enhanced, or DEP™ versions of existing drugs are under development. The most advanced of these is DEP™ docetaxel, a dendrimer-enhanced version of docetaxel (Taxotere®) which is in clinical development. In preclinical studies DEP™ docetaxel has shown significant tumour-targeting and superior anti-cancer effects across a range of important cancer types including breast, prostate, lung and ovarian tumour, when compared to Taxotere® (docetaxel).

In agrochemicals, Starpharma has a series of partnerships with leading industry players, as well as internal programs including an enhanced version of glyphosate (the active ingredient in Roundup®).

Starpharma’s headquarters and research facilities are located in Melbourne, Australia. Starpharma principally consists of two operating companies, Starpharma Pty Ltd in Australia and Dendritic Nanotechnologies, Inc. in USA, both with a comprehensive intellectual property portfolio.

Founded in 1996, Starpharma listed on the Australian Securities Exchange in 2000 (ASX: SPL). Starpharma securities also trade in the US under the American Depository Receipts (ADR) program, and are listed on the OCTQX platform (OTCQX: SPHRY). OTCQX is the premium tier of the US Over-the-Counter (OTC) marketplace, providing non-US companies with a visible cross-listing to access US investors, without the duplicative regulatory costs required of listing on a traditional US exchange.

About CEO Dr. Jackie Fairley B.Sc., B.V.Sc. (Hons), MBA

Jackie Fairley has 25 years of operational experience in the pharmaceutical and biotechnology industries working as a CEO since 2000. Prior to that she held business development, licensing and general management roles with companies including CSL and Faulding (now Hospira).

In 2006, Jackie was appointed CEO of ASX-listed biotechnology company Starpharma Holdings. Under her leadership, the company has been promoted to the ASX300, has developed several new and valuable commercial applications for its proprietary polymer technology and signed a number of strategically important commercial deals with companies including Astra Zeneca, Okamoto and Ansell. Starpharma has also significantly strengthened its institutional shareholder base, attracting investment from major European, US and Asian funds.

Jackie holds first class honours degrees in Science (pharmacology and pathology) and Veterinary Science from Melbourne University and was a practicing veterinary surgeon prior to joining CSL in 1989. Whilst at CSL she obtained an MBA from the Melbourne Business School, where as top student in her final year, she was the recipient of the prestigious Clemenger Medal. Jackie is also a Graduate of the Australian Institute of Company Directors.

In addition to her role at Starpharma, Jackie has served on the Board of the Melbourne Business School since 2010 and sits on the Investment Committee of Mark Carnegie’s Innovation Fund. She also sits on a number of specialist Government advisory committees.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more information visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About HealthTech Talk Live
HealthTech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on HealthTech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2766291
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2766293

Interview Press/ Media
Matthew BIRD
President
1-800-PublicRelations
+1 (917) 409-8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog 1800 Public Relations, 1800PR, 1800publicrelations.com, ASX, Ben Chodor, Clear Channel, Dr. Jackie Fairley, Health Tech Talk, Health Tech Talk Live, iHeart Radio, OTCQX, SPHRY, SPL, Starpharma, Starpharma Holdings Limited Comments Off Read more...

03 Feb

WEGO Health CEO and Founder Jack Barrette to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live” on January 31, 2015

Live Interview Airs on “Health Tech Talk Live,” Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT

BOSTON, MA–(Jan 30, 2015) – WEGO HEALTH, a network of over 100,000 of the most influential members of the online health community, announced today that Chief Executive Officer (CEO) Jack Barrette will be interviewed live on iHeart Radio’s Health Tech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM tomorrow, at 3:00pm ET. In this exclusive double-segment interview, Mr. Barrette will discuss how the company is focused on the empowerment of patients that drive the healthcare conversation online, across virtually every health topic and condition. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: January 31, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: iHeart Radio / Clear Channel
Station: 640 WGST AM
Show: Health Tech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About WEGO Health
WEGO Health connects organizations to tens of millions of engaged health consumers by activating our trusted network of patient influencers. We have been a trusted partner to patient leaders and their communities since 2007. We’ve developed a range of solutions to meet business needs and to support our patient influencer members — including insights, recruitment, collaboration and activation.

The WEGO Health network includes over 100,000 patient influencer members from virtually every health condition. They are bloggers, tweeters, pinners, and leaders of Facebook pages — these are the empowered patients that drive the healthcare conversation online, across virtually every health topic and condition.

To learn more about WEGO Health, visit: http://www.wegohealthsolutions.com/

About CEO and Founder Jack Barrette
Jack Barrette is CEO of WEGO Health, a social network that empowers over 100,000 patient influencers to help others and to drive health innovation. WEGO Health connects companies to millions of engaged health consumers through this trusted network of patient influencers for insights, recruiting, collaboration and activation. Before founding WEGO Health, Jack was Category Development Officer for Health at Yahoo! Jack is a frequent public speaker and author who tweets @healthyjack.

About iHeart Radio / Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s Health Tech Talk Radio Show or visit www.Health TechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2758282
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2758285

Interview Press/Media
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog Ben Chodor, Clear Channel, Health Tech Talk, Health Tech Talk Live, iHeart Radio, Jack Barrette, WEGO Health Comments Off Read more...

03 Feb

Frozenplease.com Author Agnes Fischer to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios — 640 WGST AM’s “Health Tech Talk Live” on January 31, 2015

Live Interview Airs on “Health Tech Talk Live,” Hosted by Ben Chodor, 3:30pm ET/12:30pm PT/2:30pm CT

NEW YORK, NY–(Jan 30, 2015) – iHeart Radio / Clear Channel Atlanta Studios — 640 WGST AM’s Health Tech Talk Live hosted by Ben Chodor is proud to announce that author Agnes Fischer of Frozenplease.com, an enlightening record about the urgency of re-defining birth control in today’s modern era, will be interviewed live tomorrow at 3:30pm ET. In this exclusive double-segment interview, Ms. Fischer will discuss the general lack of dialogue with our doctors about fertility, why we should be striving for a new generation of young women who have a clear understanding of all forms of birth control much earlier in life, and her personal journey in preserving her chances of creating a family in the future.

Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: January 31, 2015
Start Time: 3:30pm ET | 12:30pm PT | 2:30pm CT (U.S.)
Network: iHeart Radio / Clear Channel
Station: 640 WGST AM
Show: Health Tech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About Author Agnes Fischer
Agnes Fischer is a business leader who has worked in advertising across major global brands at the world’s leading agencies for the past 15 years. Her career has spanned major CPG’s across multi media. While she continues on in the advertising world, she has recently set her sights on promoting a much more personal mission around fertility education. As a woman who wanted to wait to start a family so she could live life to the fullest in her 20’s and early 30’s, she believes that there is too much misinformation, and too little dialogue about what it really takes to get pregnant, especially after a certain age. And this misinformation can have irreversible consequences. In an effort to ensure women are asking the right questions and understand all of their options, she has started Frozenplease.com.

About Frozenplease.com
Frozenplease.com is a blog about re-defining birth control. Agnes Fischer believes it’s time for an updated version of birth control: Birth Control 2.0.

Frozenplease.com takes a more in depth and occasionally ironic look at the current definition of birth control; the current definition is narrow, one-sided and occasionally misleading. She suggests that when control means only one thing, prevention, it leads to certain assumptions around how the reproductive system works. She also suggests that the narrow definition of birth control, combined with the lack of dialogue with our doctors, and a media landscape that bombards us with images of ‘older’ moms, leads women to believe that they have plenty of time.

Most women don’t have a good sense of their own reproductive health until they are in a position of having tried to conceive naturally for at least a year. Since most doctors don’t run tests until you’ve been trying for about that long, depending on your age. New generations of young women should have a clear understanding of all forms of birth control much earlier in life. The aim of the blog is to promote real conversations, earlier, amongst women, and between women and their doctors about the realities of fertility. Ultimately, the hope is that egg freezing and other fertility treatments are topics much more openly discussed, and much more accessible.

The blog, Frozenplease.com will be a fresh diary of personal journeys and represent the point of view of women who have experienced either having their eggs frozen, or other fertility treatments. It provides a unique perspective and human voice in a category cluttered with cold, clinical information that doesn’t help shed light on the human side of fertility. It hopes to add to the dialogue in a way that helps make this topic less extreme and more main stream.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
Health Tech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s Health Tech Talk Live. Visit iHeart Radio’s Health Tech Talk Radio Show or visit www.Health TechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2758300

Press/ Media
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog 640 WGST, Agnes Fischer, Ben Chodor, Blog, Clear Channel, FrozenPlease.com, Health Tech Talk, Health Tech Talk Live, iHeart Radio Comments Off Read more...

28 Jan

JEMS Technology CEO Kevin Lasser to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios — 640 WGST AM’s “HealthTech Talk Live” on January 24, 2015

Live Interview Airs on “HealthTech Talk Live,” Hosted by Ben Chodor, 3:00pm ET/12:00pm PT/2:00pm CT

ORION, MI–(Jan 23, 2015) – JEMS Technology, a telehealth solutions company that improves security, immediacy, quality, and mobility, announced today that Chief Executive Officer (CEO) Kevin Lasser will be interviewed live on iHeart Radio’s HealthTech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios — 640 WGST AM tomorrow, Saturday at 3:00pm ET. In this exclusive double-segment interview, Mr. Lasser will discuss how Healthcare providers have suffered without a reliable telemedicine system for secure real-time mobile until “The JEMS™ Mobile Health System.” The system is available everywhere, including over 3G, 4G, and “coffee shop” Wi-Fi. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: January 24, 2015
Start Time: 3:00pm ET | 12:00pm PT | 2:00pm CT (U.S.)
Network: iHeart Radio / Clear Channel
Station: 640 WGST AM
Show: HealthTech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About JEMS Technology
Headquartered in Orion, Mich., JEMS Technology’s focus is simple: Consult. Anytime. Anywhere. It specializes in secure, encrypted (HIPAA compliant) real-time video to hand held devices, including the iPhone, iPad, Android-based phones and Android-based tablets. JEMS Technology is focused on the healthcare market, where remote access to secure live video can assist healthcare providers to deliver better care. From real-time video to phone connectivity, JEMS Technology is effective, easy-to-use and easy to implement.

The JEMS platform is adaptable and scalable — the JEMS suite of solutions is being utilized in various health care disciplines (tele-neurology, tele-ALS, tele-OR, tele-OB, tele-cardiology, etc….) in both private and public institutions (DHS, VA, Department of Justice). JEMS is also delivering immediate best in class health care for better outcomes from places other than health care facilities (first responder vehicles, residences, etc…).

Additionally, JEMS is now being utilized in non-healthcare markets. One such example is “tele-engineering.” Rather than travel to various manufacturing plants to repair equipment, an engineer can advise others on how to make those repairs in an immediate, efficient and secure manner from the convenience of their smart device.

For more information on JEMS Technology, visit www.JEMSTech.com.

About CEO Kevin Lasser
Mr. Kevin Lasser has 29 years of experience in business building, finance, and technology solutions. Mr. Lasser is Chief Executive of JEMS Technology — the mobile health care solution that provides a consult anytime, anywhere. He oversees global business operations for JEMS — which is becoming the preferred tele health choice for health care providers in North America, and Asia in both private and public institutions. Additionally, he is a committee member of the inaugural mobile health HIMSS (Healthcare Information and Management Systems Society) committee and past chair of MTAM’s (Mobile Technology Association of Michigan) mHealth Advisory Council.

Prior to JEMS, Mr. Lasser was Chief Executive Officer and co-founder of Encryption Security Solutions (ESS) and Pure Entropy Technologies (PET) where he led both companies in becoming best in class providers of encryption/cyber security solutions to private (through ESS) and public (through PET) institutions.

Prior to ESS and PET, Mr. Lasser was President and founder of Sage Financial Corporation (Sage). Sage was consistently honored with “Top Ten Money Finders Group Awards” from esteemed financial organizations such as GE Capital, Pitney Bowes Financial and Maryland National Financial Corp. Sage funded approximately $220 million for small to mid-size businesses over a ten year period.

Mr. Lasser is a well sought after key thought leader on matters of tele health. He has spoken on many topics including — “The ROI in health care on mobile devices,” “Bio Medical Wireless Technologies,” “Health Care Technology for Critical Access Facilities,” “The impact of Mobile Devices in Healthcare,” and the recipient of numerous professional awards.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more information visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About HealthTech Talk Live
HealthTech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on HealthTech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2753767
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2753770

Interview Press / Media Contact:
Matthew BIRD
President
1-800-PublicRelations
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog Ben Chodor, Health Tech Talk, Health Tech Talk Live, JEMS Technology, Kevin Lasser Comments Off Read more...

28 Jan

LEAGUE CEO and Founder Michael Serbinis to Be Interviewed Live on iHeart Radio / Clear Channel Atlanta Studios – 640 WGST AM’s “Health Tech Talk Live” on January 24, 2015

Live Interview Airs on “HealthTech Talk Live,” Hosted by Ben Chodor, 3:30pm ET/12:30pm PT/2:30pm CT

TORONTO, ON–(Jan 23, 2015) – iHeart Radio’s Health Tech Talk Live announced today that LEAGUE CEO and Founder, Michael Serbinis, will be interviewed by host Ben Chodor. Serbinis previously founded global digital eReading company Kobo which sold to Rakuten for $315M and DocSpace which sold to Critical Path for $568M. Serbinis will talk about why the healthcare industry is ripe for change, how consumers will disrupt institutionally-driven care, and how his world-class team will transform our approach to preventative health.

The interview will be broadcasted nationwide on iHeart Radio/Clear Channel Atlanta Studios — 640 WGST AM this Saturday at 3:30pm ET. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: January 24, 2015
Start Time: 3:30pm ET | 12:30pm PT | 2:30pm CT (U.S.)
Network: iHeart Radio / Clear Channel
Station: 640 WGST AM
Show: HealthTech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About LEAGUE
LEAGUE is the future of health. The digital health and wellness platform is designed to help people live healthier, happier lives — every day. The LEAGUE platform will help people connect with a league of professionals dedicated to helping them reach their health and wellness goals through personalized insights, programs and recommendations. The platform is set to launch in early 2015. Healthcare professionals and consumers interested in participating in the company’s beta program can find more information at www.JoinLEAGUE.com.

About CEO and Founder Michael Serbinis
Michael Serbinis is the CEO and Founder of LEAGUE. He is a visionary entrepreneur who has built transformative technology platforms across several industries.

Most recently Michael was the founder and CEO of Kobo, a digital reading company that burst onto the publishing scene in 2009, driving $110M in sales in its first year. Under Michael’s leadership, Kobo became the only global competitor to Amazon’s Kindle with 20-million customers in 190 countries. Michael sold Kobo to Japanese Internet giant Rakuten for $315M in 2012.

Prior to Kobo, Michael founded and sold cloud storage pioneer DocSpace for $568M in 2000 to Critical Path, a global provider of messaging services, which ran one-third of the world’s email. Michael also developed network routing technology at Microsoft, and search engine technology at Zip2, the latter later sold to Altavista for $300M.

Michael is currently the founder of Three Angels Capital, a member of the Board of the Perimeter Institute for Theoretical Physics, the Board of the Creative Destruction Lab, the Board of Trustees at the Ontario Science Centre, and is a member of YPO. He holds a Bachelor of Science degree in Engineering Physics from Queens University and a Masters of Science in Industrial Engineering from the University of Toronto. Once upon a time, Michael developed a quantum cryptography system, and a high temperature superconductor propulsion system that won Gold at the Intel International Science & Engineering Fair, and numerous other awards, sponsorships and jobs from NASA, Rockwell Aerospace and Intel.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About Health Tech Talk Live
HealthTech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on Health Tech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2754328
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2754331

Interview Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
+1 (917) 409-8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog 1800 Public Relations, 1800PR, 1800publicrelations.com, Ben Chodor, Health Tech Talk, Health Tech Talk Live, LEAGUE, Michael Serbinis Comments Off Read more...

19 Jan

eCaring, Inc. CEO Robert M. Herzog to Be Interviewed Live on iHeart Radio/Clear Channel Atlanta Studios – 640 WGST AM’s “HealthTech Talk Live” on January 17, 2015

Live Interview Airs on “HealthTech Talk Live,” Hosted by Ben Chodor, 3:30pm ET/12:30pm PT/2:30pm CT

NEW YORK, NY–(Jan 17, 2015) – eCaring, Inc., a company that helps keep people out of the hospital by generating essential real time health care data from the home, announced today that Chief Executive Officer (CEO) Robert M. Herzog will be interviewed live on iHeart Radio’s HealthTech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/Clear Channel Atlanta Studios – 640 WGST AM this Saturday at 3:30pm ET.

In this exclusive double-segment interview, Mr. Herzog will discuss the company’s unique cloud-based system which integrates significant behavioral, clinical and medication adherence data to manage and monitor seniors and people with chronic conditions. The system has been proven to reduce emergency room and hospital visits as well as hospital readmissions, saving $300-$500 per patient per month. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: January 17, 2015
Start Time: 3:30pm ET | 12:30pm PT | 2:30pm CT (U.S.)
Network: iHeart Radio / Clear Channel
Station: 640 WGST AM
Show: HealthTech Talk Live
Host: Ben Chodor
iHeart Radio Live Stream: CLICK HERE

About eCaring
eCaring keeps people out of the hospital by generating essential real time health care data from the home. Our unique cloud-based system integrates significant behavioral, clinical and medication adherence data to manage and monitor seniors and people with chronic conditions. That information is filtered for care managers and providers, hospitals and health plans, generating actionable alerts that enable timely interventions which keep small problems in the home from leading to big ones in the hospital. A single platform manages all conditions, providing a unique new source of major health care data. The results are more efficient allocation of resources, improved information sharing, and reduced overall cost of care.

About CEO and Founder Robert M. Herzog
Robert is a pioneer in applying emerging technologies to unique business problems, and has worked extensively and successfully both as an entrepreneur and as senior executive with startup companies such as Motionbox, Diva, ON2 Corp, Softcom, Granite Films and City Winery, major corporations including JPMorgan Chase, Cahners Communications and the Sarnoff Research Center, and not-for-profits including New Jersey Appleseed and Ecotrust.

While working for the mayor of NYC, he was the creator and Director of New York City’s Energy Office. He has also taught public school and is an author and filmmaker. He graduated from Williams College and has a Master’s from the New School.

Robert’s interest and involvement in home-based healthcare emerged several years ago when he was deeply involved in the home and extended care of his mother Grace. The issues both she and he encountered ensuring that she received proper treatment gave him the initial understanding of the problems eCaring was subsequently designed to solve.

About iHeart Radio/Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About HealthTech Talk Live
HealthTech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on HealthTech Talk Live radio show, please contact 1800PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Press/ Media Contact:
Matthew BIRD
President
1-800-PublicRelations, Inc.
917.409.8211
matt.bird@1800pr.com
www.1800pr.com

By Rachel Eduardo Blog 1800 Public Relations, 1800PR, 1800publicrelations.com, 640 WGST AM, Ben Chodor, Clear Channel, eCaring, Health Tech Talk Live, HealthTech Talk Live, iHeart Radio, Robert M. Herzog Comments Off Read more...

13 Jan

HealthLoop CEO Todd Johnson to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios — 640 WGST AM’s “HealthTech Talk Live” on January 10, 2015

Live Interview Airs on “HealthTech Talk Live,” Hosted by Ben Chodor, 3:30pm ET/12:30pm PT/2:30pm CT

MOUNTAIN VIEW, CA–(Jan 9, 2015) – HealthLoop, the Silicon Valley digital health darling that automates follow-up care between doctors, patients and care-givers between visits with clinical information, announced today that Chief Executive Officer (CEO) Todd Johnson will be interviewed live on iHeart Radio’s debut episode of HealthTech Talk Live hosted by Ben Chodor and broadcasted nationwide on iHeart Radio/ Clear Channel Atlanta Studios – 640 WGST AM this Saturday at 3:30pm ET. In this exclusive double-segment interview, Mr. Johnson will talk about the innovations occurring in digital health as a result of shifting incentives in the healthcare delivery system. Learn about the next wave of digital health platforms for patients, physicians and healthcare insurers. Take an in depth look into the CEO behind the company’s success. Learn about the company’s technology and how it is transforming healthcare delivery and rethinking the ways that patients experience healthcare.

Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

Date: January 10, 2015
Start Time: 3:30pm ET | 12:30pm PT | 2:30pm CT (U.S.)
Network: iHeart Radio / Clear Channel
Station: 640 WGST AM
Show: HealthTech Talk Live
Host: Ben Chodor

About HealthLoop
HealthLoop is a cloud-based platform that automates follow-up care; keeping doctors, patients and care-givers connected between visits with clinical information that is insightful, actionable, and engaging. Our peer-reviewed follow-up plans automate the routine aspects of care while tracking patient progress and monitoring clinical areas of concern. Our analytics engine sifts through and filters the deluge of patient-generated data in real-time; focusing the care team’s time and attention on patients who need them the most. For more information please visit www.HealthLoop.com.

About CEO Todd Johnson
Todd is a serial healthcare information technology entrepreneur committed to building a great product, team and company. Todd has a proven track record of cultivating great ideas into great businesses while striving to build great company cultures and brands. Prior to joining HealthLoop, Todd was the founder and CEO of Salar, Inc. — a Baltimore, MD based provider of acute care physician charge capture and documentation solutions. Working with the nation’s leading medical centers and physicians, Salar grew profitably year after year before being sold in 2011.

About iHeart Radio/ Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. For more Information Visit: http://www.iheart.com/live/talk-radio-640-wgst-6066/?autoplay=true&pname=15153&campid=play_bar&cid=main.html.

About HealthTech Talk Live
HealthTech Talk Live broadcasts live weekly on iHeart Radio / Clear Channel nationwide from 640 WGST AM Atlanta, 3:00pm – 4:00pm EST every Saturday. Host Ben Chodor interviews the front-page emerging health tech innovators and titans about the latest in digital health technology, human ingenuity, bio-tech medical advancements and health tech capital market trends. Learn how the experts use risk management techniques and clinical trials to build fully diversified portfolios and what it takes to put up big board earnings from making people healthier. It’s a fast moving, high-energy show… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s HealthTech Talk Live. Visit iHeart Radio’s HealthTech Talk Radio Show or visit www.HealthTechTalk.com.

If you’re interested in being a guest on HealthTech Talk Live radio show, please contact 1-800-PublicRelations at support@1800pr.com “ATTN: Health Tech Talk Guest Inquiry.”

Contact:

Interview
Matthew BIRD
President
1-800-PublicRelations
+1 (917) 409-8211
matt.bird@1800pr.com
www.1800pr.com

By Matt Bird, President Blog 1800PR, 1800PublicRelations, Ben Chodor, Digital Health, Doctors, Follow-up Care, Health Tech Talk, Health Tech Talk Live, Healthcare, healthcare delivery, HealthLoop, HealthTech Talk Live, Patients, Todd Johnson Comments Off Read more...

Posts tagged “Health Tech Talk Live”

CONTACT INFORMATION